| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.046 | 0.7 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |